ArticleJournal of health monitoring2017
12-Month prevalence of known diabetes mellitus in Germany.
Article in Journal of health monitoring, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.
- Environmental burden of disease resulting from long-term nitrogen dioxide exposure in Germany.BMC public health · 2025Pooled it
- Trial
- Assessing the reliability and validity for metabolic syndrome diagnosis using point-of-care analyzers in a mobile setup - a pilot study.BMC primary care · 2026Article
- Retrospective analysis of the diagnostic spectrum of histological nephropathies from the Magdeburg kidney biopsy cohort (MD-KBC).BMC nephrology · 2025Article
- Vascular risk profile and changes of arterial hypertension after surgical revascularization in adult Moyamoya patients.Scientific reports · 2024Article
- An Outpatient Management Strategy Using a Coronataxi Digital Early Warning System Reduces Coronavirus Disease 2019 Mortality.Open forum infectious diseases · 2022Article
- Health situation of adults in Germany - Results for selected indicators from GEDA 2019/2020-EHIS.Journal of health monitoring · 2021Article
- Population with an increased risk of severe COVID-19 in Germany. Analyses from GEDA 2019/2020-EHIS.Journal of health monitoring · 2021Article
- Physical inactivity in healthy, obese, and diabetic adults in Germany: An analysis of related socio-demographic variables.PloS one · 2021Article
- Participation in structured diabetes mellitus self-management education program and association with lifestyle behavior: results from a population-based study.BMJ open diabetes research & care · 2020Article
- Adjusting selection bias in German health insurance records for regional prevalence estimation.Population health metrics · 2019Article
- Appropriation of Mobile Health for Diabetes Self-Management: Lessons From Two Qualitative Studies.JMIR diabetes · 2019Article
- The Perioperative Care of Older Patients.Deutsches Arzteblatt international · 2019Review
- Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - A review in the framework of the Diabetes Surveillance.Journal of health monitoring · 2017Article
- Diabetes Surveillance in Germany - Background, concept and prospects.Journal of health monitoring · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a metabolic disease involving chronic dysfunction of blood sugar regulation; if left untreated, it can result in serious secondary illnesses. In 2014 and 2015, a total of 7.0% of women and 8.6% of men in Germany with an age of 18 and over reported having diabetes mellitus in the past 12 months (these figures do not include gestational diabetes). There are significant differences in the 12-month prevalence among adults: the prevalence of known diabetes increases significantly with age, and is particularly high among people with a low educational status and those living in Saxony-Anhalt or Brandenburg. The Robert Koch Institute is currently developing a diabetes surveillance system in order to establish a data-based fundament for guiding health policy decisions in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.